ReviewBiosensors2025
POC Sensor Systems and Artificial Intelligence-Where We Are Now and Where We Are Going?
Review in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Cell-Free Protein Synthesis in Porous Parylene Scaffolds.Small methods · 2026Article
- Emergency Clinical Decision for Sports Injury Management: A Wearable Sensor-Driven Framework from Training to Rehabilitation.Biosensors · 2026Review
- Laser-Induced Graphene Dual Optical/Electrochemical Platform for In-Chip Sensing Applications.Sensors (Basel, Switzerland) · 2026Article
- Pharmacists in modern primary care and management of diseases: an evidence-based perspective on emerging technologies.BioImpacts : BI · 2026Article
- AI-augmented frameworks for enhancing Alzheimer's disease clinical trials: A memory clinic perspective.The journal of prevention of Alzheimer's disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Integration of machine learning (ML) and artificial intelligence (AI) into point-of-care (POC) sensor systems represents a transformative advancement in healthcare. This integration enables sophisticated data analysis and real-time decision-making in emergency and intensive care settings. AI and ML algorithms can process complex biomedical data, improve diagnostic accuracy, and enable early disease detection for better patient outcomes. Predictive analytics in POC devices supports proactive healthcare by analyzing data to forecast health issues and facilitating early intervention and personalized treatment. This review covers the key areas of ML and AI integration in POC devices, including data analysis, pattern recognition, real-time decision support, predictive analytics, personalization, automation, and workflow optimization. Examples of current POC devices that use ML and AI include AI-powered blood glucose monitors, portable imaging devices, wearable cardiac monitors, AI-enhanced infectious disease detection, and smart wound care sensors are also discussed. The review further explores new directions for POC sensors and ML integration, including mental health monitoring, nutritional monitoring, metabolic health tracking, and decentralized clinical trials (DCTs). We also examined the impact of integrating ML and AI into POC devices on healthcare accessibility, efficiency, and patient outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.